Announcing a new publication for Acta Materia Medica journal. Bioresponsive materials have gained prominence as innovative ...

Synthego has expanded its CRISPR solutions portfolio with the launch of GMP SpCas9, offering researchers a powerful solution to enhance CRISPR-based therapeutic development. The launch of GMP ...

SRF published this paper to document and share the critical progress made in advancing SYNGAP1 therapeutic development and to share our roadmap for other patient advocacy groups (PAGs) focused on ...

Shrub Oak International School sets the benchmark in autism education as a leading therapeutic program for autistic children, adolescents, and young adults with co-occurring mental health conditions.

The insights and progress you’ve gained from your current therapeutic relationship can serve as valuable building blocks for your continued growth with a new provider.

Dr. Michael Rafii – Medical Director, Alzheimer’s Therapeutic Research Institute, discusses the progress made in the prevention of Alzheimer's Disease.

“We made tremendous progress toward this goal in 2024, with accomplishments including substantially advancing MGX-001, our potentially curative development candidate for hemophilia A, as well as ...

The future of relationship healing As therapeutic approaches continue evolving, the distinction between individual and group therapy becomes more nuanced.

The launch of GMP SpCas9 enables researchers to bundle the nuclease with IND-enabling or GMP sgRNAs into a convenient, unified package, optimizing processes and driving therapeutic progress.

Metagenomi Highlights Progress Across Therapeutic Portfolio and Outlines Anticipated Milestones PRESS RELEASE GlobeNewswire Jan. 16, 2025, 08:55 AM ...